Mesoblast Announces Changes to Board of Directors’ Leadership Roles
January 01, 2026 18:02 ET | Source: Mesoblast Limited NEW YORK, Jan.…
Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line
December 29, 2025 18:57 ET | Source: Mesoblast Limited Mesoblast has option…
Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD
December 11, 2025 18:22 ET | Source: Mesoblast Limited NEW YORK, Dec.…
